Trace Biosciences
PrivateLast Round
Series A
Jul 28, 2026
Total Funding Raised
$3.99M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Trace Biosciences operates in Healthcare & Life Sciences and is based in Beaverton, Oregon. Its latest recorded funding round was a Grant round in September 2023.
Trace Biosciences is a biotechnology company that develops nerve-targeted fluorescent imaging agents designed to improve surgical safety by enabling real-time visualization of nerves.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trace Biosciences Comparables
Compare Trace Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alume Biosciences | 93% | |
| Illuminare Biotechnologies | 87% | |
| Curadel Surgical Innovations, Inc. | 82% |
For institutional investors. Book with your work email.
Trace Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2026 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Jul 1, 2023 | ||||
| Pre Seed | May 17, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
Grant | Nov 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trace Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| ONAMI | Pre Seed |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| ARPA-H | Grant |
| SciFounders | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Raised $8.3M in seed funding.
- May 13, 2026
Monthly visitors increased 45% MoM.
For institutional investors. Book with your work email.
Trace Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trace Biosciences's valuation, stock price, and market status.
Is Trace Biosciences a public or private company?
Trace Biosciences is a private company.
What is the current stock price of Trace Biosciences?
Trace Biosciences is a private company, so its shares have no public market price. Caplight tracks Trace Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trace Biosciences worth (valuation)?
Valuation information for Trace Biosciences is not publicly available.
Can I buy Trace Biosciences stock?
Trace Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trace Biosciences's last funding round?
Trace Biosciences's most recent funding round was Series A on July 28, 2026.
Who are the main investors in Trace Biosciences?
Key investors in Trace Biosciences include National Cancer Institute, ONAMI, National Institute of Neurological Disorders and Stroke (NINDS), ARPA-H, SciFounders.
Will Trace Biosciences IPO soon?
No public IPO plans have been announced for Trace Biosciences.
How can I track Trace Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Trace Biosciences's shares on secondary markets.